• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of decalcification on receptor status in breast cancer.

作者信息

Darvishian Farbod, Singh Baljit, Krauter Stephanie, Chiriboga Luis, Gangi Maryann D, Melamed Jonathan

出版信息

Breast J. 2011 Nov-Dec;17(6):689-91. doi: 10.1111/j.1524-4741.2011.01168.x. Epub 2011 Oct 17.

DOI:10.1111/j.1524-4741.2011.01168.x
PMID:21999708
Abstract
摘要

相似文献

1
Impact of decalcification on receptor status in breast cancer.脱钙对乳腺癌受体状态的影响。
Breast J. 2011 Nov-Dec;17(6):689-91. doi: 10.1111/j.1524-4741.2011.01168.x. Epub 2011 Oct 17.
2
Triple negative breast cancer: clinicopathological characteristics and treatment strategies.三阴性乳腺癌：临床病理特征与治疗策略
Breast Cancer. 2009;16(4):252-3. doi: 10.1007/s12282-009-0140-x.
3
Triple negative and basal-like breast cancer in East Africa.东非的三阴性和基底样乳腺癌。
Breast J. 2011 Jul-Aug;17(4):438-40. doi: 10.1111/j.1524-4741.2011.01096.x.
4
Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients.比较转移性乳腺癌患者循环肿瘤细胞和原发肿瘤中雌激素和孕激素受体状态。
Gynecol Oncol. 2011 Aug;122(2):356-60. doi: 10.1016/j.ygyno.2011.04.039. Epub 2011 May 24.
5
Estrogen and progesterone receptor status of primary breast cancer: relationship with the pattern of first metastasis and survival.原发性乳腺癌的雌激素和孕激素受体状态：与首次转移模式及生存的关系。
Neoplasma. 1992;39(6):349-52.
6
The association of infrared imaging findings of the breast with hormone receptor and human epidermal growth factor receptor 2 status of breast cancer.乳腺癌红外成像表现与激素受体及人表皮生长因子受体 2 状态的相关性。
Acad Radiol. 2011 Feb;18(2):212-9. doi: 10.1016/j.acra.2010.09.016. Epub 2010 Dec 3.
7
Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients.乳腺癌患者临床、病理状态、激素受体与C-erbB-2癌蛋白的相关性
Gan To Kagaku Ryoho. 2000 May;27 Suppl 2:600-6.
8
[Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].[绝经后女性118例雌激素受体阳性乳腺浸润性导管癌中孕激素受体状态的临床生物学意义]
Rev Esp Med Nucl. 2000 Jun;19(3):244-6.
9
Commentary: hormone receptor testing in breast cancer: a distress signal from Canada.评论：乳腺癌中的激素受体检测：来自加拿大的一个警示信号。
Oncologist. 2008 Nov;13(11):1134-6. doi: 10.1634/theoncologist.2008-0184. Epub 2008 Nov 5.
10
[Prognostic factors of breast cancer].[乳腺癌的预后因素]
Zhonghua Bing Li Xue Za Zhi. 2011 Feb;40(2):73-6.

引用本文的文献

1
HER2 Intratumoral Heterogeneity in Breast Cancer, an Evolving Concept.乳腺癌中HER2肿瘤内异质性：一个不断发展的概念
Cancers (Basel). 2023 May 9;15(10):2664. doi: 10.3390/cancers15102664.
2
Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer.原发与转移性乳腺癌中雌激素、孕激素和人表皮生长因子受体 2 的不一致性。
Breast Cancer Res Treat. 2020 Aug;183(1):137-144. doi: 10.1007/s10549-020-05746-8. Epub 2020 Jul 1.
3
Applying the New Guidelines of HER2 Testing in Breast Cancer.
应用乳腺癌 HER2 检测新指南。
Curr Oncol Rep. 2020 Apr 29;22(5):51. doi: 10.1007/s11912-020-0901-4.
4
Hormone receptor and HER2 assessment in breast carcinoma metastatic to bone: A comparison between FNA cell blocks and decalcified core needle biopsies.激素受体和 HER2 在乳腺癌骨转移中的评估：细针抽吸细胞块与脱钙芯针活检的比较。
Cancer Cytopathol. 2020 Feb;128(2):133-145. doi: 10.1002/cncy.22226. Epub 2019 Dec 28.
5
Influence of decalcification procedures on immunohistochemistry and molecular pathology in breast cancer.脱钙程序对乳腺癌免疫组织化学和分子病理学的影响
Mod Pathol. 2016 Dec;29(12):1460-1470. doi: 10.1038/modpathol.2016.116. Epub 2016 Aug 26.
6
Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT.使用89Zr-曲妥珠单抗PET/CT检测HER2阴性原发性乳腺癌患者中的HER2阳性转移灶。
J Nucl Med. 2016 Oct;57(10):1523-1528. doi: 10.2967/jnumed.115.172031. Epub 2016 May 5.
7
Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.使用生物标志物指导转移性乳腺癌女性全身治疗决策：美国临床肿瘤学会临床实践指南
J Clin Oncol. 2015 Aug 20;33(24):2695-704. doi: 10.1200/JCO.2015.61.1459. Epub 2015 Jul 20.
8
Testing for her2 in breast cancer: current pathology challenges faced in Canada.乳腺癌中 HER2 的检测：加拿大当前面临的病理学挑战。
Curr Oncol. 2012 Dec;19(6):315-23. doi: 10.3747/co.19.1173.